Form 4: Thermo Fisher Scientific Director Jennifer M. Johnson Reports Acquisition of Phantom Stock Units

Director Jennifer M. Johnson reported the acquisition of phantom stock units in Thermo Fisher Scientific Inc. through the company's Deferred Compensation Plan for Directors.

Summary

• On March 30, 2024, Jennifer M. Johnson, a director of Thermo Fisher Scientific Inc., acquired 53.77 phantom stock units.
• These units were credited to her account under the Issuer's Deferred Compensation Plan for Directors at a price of $581.21 per unit.
• The phantom stock units are convertible into common stock on a 1-for-1 basis and are distributable as stock upon cessation of director service or a change of control.
• Johnson also disclaims beneficial ownership of equity securities of the Issuer held by Franklin Templeton subsidiaries.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company through a compensation plan.

Positives

• The acquisition of phantom stock units demonstrates the director's continued investment in the company's future.
• The Deferred Compensation Plan for Directors aligns the interests of directors with those of shareholders.

Future Outlook

The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Management Comments

• Reporting Person disclaims beneficial ownership of such securities.

Industry Context

This filing is a routine disclosure of a director's compensation and holdings in the company, which is common practice for publicly traded companies.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with those of shareholders, potentially fostering better corporate governance.

Key Dates